JW Lifescience Corporation Stock: price and insider trades · South Korea
JW생명과학
No insider purchase over the last 90 days. The latest, by FILLIMITED, was filed 10 Jul 2026.
JW Lifescience Corporation: what insiders have been doing
JW Lifescience Corporation, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). From 1 November 2025 to 1 November 2026, the disclosure feed for JW Lifescience Corporation logged 6 filings by 3 insiders.
Only purchases show up on the open market, 4 purchases in all, filed by 2 insiders. The totals do not cover 4 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 1 major shareholder.
For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 6 filings here. Looking back to 2021, when coverage begins, insiders filed 10 purchases and no sales.
The latest purchase dates back some time: it was published 121 days ago, on 10 July 2026. Between a trade and the moment it shows up on DART (FSS), the median delay is 7 days. The shorter that gap, the sooner other investors can see what insiders have done.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -5.4%Entry ₩11,110 · Close 30 Oct 2026 ₩10,510
- -1.9%Entry ₩12,400 · Close at T+365 ₩12,170
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 273,850 sharesKRXDART:20260710000222Canonical exit: 8 Oct 2026 (T+90)
- 169,099 sharesKRXDART:20260407003088Canonical exit: 29 Jun 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- 286,880 sharesKRXDART:20260102000089Canonical exit: 9 Mar 2026 (T+90)
- 809,121 sharesKRXDART:20251202000241Canonical exit: 24 Feb 2026 (T+90)
- 809,121 sharesKRXDART:20230526000640Canonical exit: 17 Aug 2023 (T+90)
- 11,500 shares@ ₩12,477.6957100.0% of flowShareKRXDART:20230526000650Canonical exit: 17 Aug 2023 (T+90)
- ●Executives0DART
- ●Executives0DART
- 809,121 sharesKRXDART:20210929000488Canonical exit: 28 Dec 2021 (T+90)
- 809,121 sharesKRXDART:20210702000219Canonical exit: 30 Sept 2021 (T+90)
- 809,121 sharesKRXDART:20210409002746Canonical exit: 8 Jul 2021 (T+90)
- ●Executives0DART
- 809,121 sharesKRXDART:20210405002120Canonical exit: 4 Jul 2021 (T+90)
- ●Executives0DART
16 of 16 declarations
About JW Lifescience Corporation
JW Life Science is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development of pharmaceutical and biotechnology products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
